AstraZeneca Gives U.S. Rights for Gout Drug to Ironwood Pharma

Agreement includes U.S. rights to ZURAMPIC and lesinurad/allopurinol fixed-dose combination in gout
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news